Investigating expression of possible targets for proteasome inhibitors in patients with diffuse large B‐cell lymphoma (DLBCL) and correlating the findings to clinical parameters and outcome. Click to show full abstract
Investigating expression of possible targets for proteasome inhibitors in patients with diffuse large B‐cell lymphoma (DLBCL) and correlating the findings to clinical parameters and outcome.
               
Click one of the above tabs to view related content.